When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CLRB - Cellectar's CRL 131 Fast Track'd for DLBCL; shares up 6% premarket
Cellectar Biosciences Inc.
The FDA designates Cellectar Biosciences' (NASDAQ:CLRB) lead candidate CLR 131 for Fast Track review for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
More news on: Cellectar Biosciences, Inc., Healthcare stocks news, Stocks on the move,